pCDNA3.1-Nanog Citations (4)

Originally described in: Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.
Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM, Zou C, Zhang YA, Tong J, Cheng L Cell Res. 2011 Jan 18. ():. PubMed Journal

---

Articles Citing pCDNA3.1-Nanog

Articles
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells. Esanov R, Belle KC, van Blitterswijk M, Belzil VV, Rademakers R, Dickson DW, Petrucelli L, Boylan KB, Dykxhoorn DM, Wuu J, Benatar M, Wahlestedt C, Zeier Z. Exp Neurol. 2016 Mar;277:171-7. doi: 10.1016/j.expneurol.2015.12.022. Epub 2015 Dec 31. PubMed
IDH1(R132H) Causes Resistance to HDAC Inhibitors by Increasing NANOG in Glioblastoma Cells. Kim GH, Choi SY, Oh TI, Kan SY, Kang H, Lee S, Oh T, Ko HM, Lim JH. Int J Mol Sci. 2019 May 31;20(11). pii: ijms20112679. doi: 10.3390/ijms20112679. PubMed
The Pluripotency Factor Nanog Protects against Neuronal Amyloid beta-Induced Toxicity and Oxidative Stress through Insulin Sensitivity Restoration. Chang CC, Li HH, Tsou SH, Hung HC, Liu GY, Korolenko TA, Lai TJ, Ho YJ, Lin CL. Cells. 2020 May 27;9(6). pii: cells9061339. doi: 10.3390/cells9061339. PubMed
Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Diaz-Tejeda Y, Guido-Jimenez MC, Lopez-Carbajal H, Amador-Molina A, Mendez-Martinez R, Gariglio-Vidal P, Lizano M, Garcia-Carranca A. Viruses. 2021 Jul 28;13(8). pii: v13081482. doi: 10.3390/v13081482. PubMed

If you have published an article using this material, please email us at to have your article added to this page.